Compare Appian Corp (APPN) vs Herbalife Nutrition Ltd (HLF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Appian Corp vs Herbalife Nutrition Ltd — how do they compare? Appian Corp trades at $25.5 (market cap $1.86B), while Herbalife Nutrition Ltd trades at $13.15 (market cap $1.36B). The key difference: Appian Corp is the larger of the two by market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, Appian Corp nearer its low. Which is the better fit depends on your goals.
| APPN | HLF | |
|---|---|---|
Market Cap | $1.86B | $1.36B |
Sector | Technology | Consumer Staples |
52-Week High | $45.64 | $19.96 |
52-Week Low | $18.72 | $7.75 |
Enterprise Value | $1.95B | $3.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Appian (APPN) trades at $25.36, up 0.48% on the day, with a bullish technical signal from moving averages and a consensus price target of $26.20. The company reported positive net income in 2025 after years of losses, with revenue growing to $726.94M and operating cash flow improving to $62.87M. Recent news highlights focus on AI strategy and enterprise adoption, though the CEO's share sale and negative shareholder equity present mixed signals.
The outlook is cautiously optimistic with revenue growth and cash flow recovery, but risks include high debt levels, negative equity, and intense competition. Analyst sentiment is mixed with a majority Hold rating. The stock offers potential from AI-driven growth but requires monitoring of profitability sustainability and balance sheet health.
Herbalife (HLF) trades at $13.15, up 1.94% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains stable revenue around $5B annually with improving debt metrics, though negative shareholder equity remains a concern. Recent Q1 2026 earnings beat expectations with EPS of $0.64 versus $0.607 expected, supported by strong international growth and successful $1.45B debt refinancing completed in April 2026.
HLF presents a value opportunity with low P/E (5.77) and P/S (0.27) ratios, but faces significant leverage risks and competitive pressures. Analyst sentiment leans bullish (58% buy ratings) despite technical weakness, with the stock's direction likely dependent on Q2 2026 results announcement scheduled for August 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →
